Intuitive Surgical (NASDAQ:ISRG) stock is getting a boost on Friday as investors celebrate approval of da Vinci 5 by the Food and Drug Administration (FDA). Da Vinci 5 is the next generation of Intuitive Surgical’s multiport robotic system that has been used in more than 7 million procedures. The newest version brings with it increased performance, an enhanced 3D imaging system and new Force Feedback technology. Myriam J. Curet, M.D., Chief Medical Officer of Intuitive Surgical, said the following about the ...

SUNNYVALE, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the U.S. Food and Drug Administration (FDA) provided 510(k) clearance for da Vinci 5, the company's next- generation multiport robotic system. "We are pleased to receive FDA clearance for our fifth-generation robotic system, da Vinci 5," said Gary Guthart, CEO. "Intuitive is committed to meaningful improvements ...

蓝筹股机会 - 蓝筹股可能是您重新获得稳定性所需的锚定点[1] - U-Haul被认为是一个被忽视的蓝筹股机会[4] - Netflix在2022年的低迷后，经历了超过200%的激增，重新确立了其蓝筹股地位[7] 科技领域 - Intuitive Surgical是一家在“硬科技”、机器人技术和全球医疗保健领域中独特的蓝筹股选择[10] - Intuitive Surgical在全球手术使用方面取得了显著增长[11] - 台积电(TSMC)受益于日本的投资和财务健康，巩固了其蓝筹股地位[19] 市场表现 - Steel Dynamics在可持续制造方面的承诺增强了其吸引力[15] - News Corp成功转向数字和订阅收入，取得了财务改善[21] - Marriott International在全球酒店行业中占据重要地位，正在扩大客户群体[24]

In the latest market close, Intuitive Surgical, Inc. (ISRG) reached $382.99, with a -1.65% movement compared to the previous day. The stock fell short of the S&P 500, which registered a loss of 0.19% for the day. At the same time, the Dow added 0.1%, and the tech-heavy Nasdaq lost 0.54%. The company's shares have seen an increase of 2.77% over the last month, not keeping up with the Medical sector's gain of 2.91% and the S&P 500's gain of 3.18%. Market participants will be closely following the financial re ...

机器人技术发展 - 机器人技术在不断发展，为多个领域带来了变革性潜力[1] - 先例研究对机器人行业的增长前景非常乐观，预测到2032年市值将达到约2831.9亿美元，为智能机器的新时代铺平道路[2] Intuitive Surgical (NASDAQ:ISRG) - ISRG是在机器人辅助手术领域的开拓者，其da Vinci手术系统在市场定位上取得了显著进展，过去五年中，该技术的安装显著增强了ISRG的市场地位[3] - ISRG在过去五年中证明了其作为多倍投资的价值，过去一年股价上涨了43%[4] - ISRG在第四季度表现出色，超过分析师的预期，非GAAP每股收益超过分析师预期11美分，收入达到19.3亿美元，比预期高出3000万美元[5] - 公司最近提交了下一代da Vinci 5平台的510(k)申请，这一阶段性推出计划表明公司在供应和制造方面做好了充分准备，确保在平台获得FDA批准时能够满足需求，巩固其在外科机器人领域的领先地位[6] Kratos (NASDAQ:KTOS) - KTOS虽然不仅专注于传统机器人应用，但在无人机领域是一家重要参与者，KTOS专注于无人系统、卫星通信、网络安全等领域，这些领域对国防和安全实体至关重要[7] - KTOS的产品和服务在过去七个季度中取得了巨大增长，Q4公司报告显示，营收同比增长10%，达到2.74亿美元，调整后的EBITDA大幅增长至2,910万美元，较去年同期的1,920万美元显著增长，展示了其强劲的增长和运营效率[8] UiPath (NYSE:PATH) - UiPath在机器人流程自动化(RPA)行业处于领先地位，通过创建、部署和管理软件机器人，巩固了该行业的看涨趋势[9] - UiPath最新的财务披露显示，年度重复收入同比增长24%，达到13.8亿美元，非GAAP运营收入大幅增长244%，突显了其财务实力和市场信心[10] - UiPath正在全力以赴发展人工智能，最近推出了Project Wingman和UiPath Autopilot，这些创新为用户通过自然语言生成自动化流程，优化日常任务提供了可能，增强了UiPath的技术优势[11] - 公司与SAP (NYSE:SAP)等合作伙伴关系以及通过其业务自动化平台增强人工智能能力的重点，对UiPath的增长战略至关重要，这些举措巩固了其在机器人和人工智能领域的领先地位，标志着其作为一个有利可图的投资选择[12]

公司表现 - 公司股票在过去一个月中表现为-0.6%，而Zacks S&P 500综合指数为+2.9%[2] - Zacks Medical - Instruments行业在此期间上涨了3.6%[2] 财务预期 - 公司当前季度预计每股收益为1.39美元，同比增长13%[5] - 公司当前财年的预期每股收益为6.18美元，同比增长8.2%[6] - 公司下一个财年的预期每股收益为7.27美元，同比增长17.7%[7] 股价评级 - 公司被评为Zacks Rank 4 (卖出)，显示股价可能在短期内表现不佳[8] 财务表现 - 公司在过去四个季度中均超过了市场预期的每股收益[13] 估值 - 公司被评为F级，表明其股价较同行公司高出一定溢价[17]

Intuitive Surgical, Inc. (ISRG) closed the latest trading day at $400.59, indicating a +0.68% change from the previous session's end. The stock's change was more than the S&P 500's daily loss of 0.12%. Elsewhere, the Dow saw a downswing of 0.25%, while the tech-heavy Nasdaq depreciated by 0.41%. Coming into today, shares of the company had gained 3.68% in the past month. In that same time, the Medical sector gained 3.58%, while the S&P 500 gained 4.83%. Market participants will be closely following the fina ...

As you may have learned recently, the "Magnificent Seven" is a group of powerhouse stocks including Nvidia, Apple, and Microsoft, most of which have benefited significantly from the enthusiasm surrounding their artificial intelligence (AI) efforts. But which would be the equivalent businesses if the same concept were applied to the healthcare sector rather than the technology sector? As it turns out, there are only four stocks that have the right combination of ongoing growth and market- outperforming retur ...

价值科技股票 - 价值科技股票在市场上似乎是个矛盾的词汇，通常价值股票稳定、成熟且增长缓慢[1] - 一些价值科技股票打破了传统趋势，在成熟、扩张、创新和依赖现有收入之间找到了平衡[2] News Corp (NASDAQ:NWSA) - News Corp 是少数有效应对媒体消费转变的传统媒体股票之一[3] - 公司在数字和订阅收入方面取得了进展，类似于软件型价值科技股票优先考虑稳定收入而非一次性或间歇性更大回报[4] Intuitive Surgical (NASDAQ:ISRG) - Intuitive Surgical 是稳定且规模庞大的医疗硬件制造商，通过引入机器人和自动化技术，实现高科技、高增长的商业模式[5] - 公司加速全球扩张，报告显示销售额增长17%，净收入几乎翻倍[6] 任天堂 (OTCMKTS:NTDOY,OTCMKTS:NTDOF) - 任天堂是少数具有稳健财务状况、庞大客户群和大量未开发盈利机会的价值科技股票之一[7] - 公司计划将其庞大的知识产权目录进行特许经营和货币化，首个项目是银幕 Zelda 改编，预计将推动公司股价上涨[8]

机器人技术应用 - 公司受益于机器人的能力，能够以比人类低得多的成本执行许多任务[1] - 机器人能够显著降低通货膨胀，使企业能够以更低的价格销售产品[1] - Symbotic公司提供用于自动化仓库功能的“机器人和软件”，与沃尔玛、Target和Albertsons等大公司签订合同[4][5][6] 公司业绩 - Symbotic公司在2023财年第一季度报告显示，营收同比增长79%，EBITDA也有所增长[7][8] - Kratos公司的无人机被认为是机器人，具有自主决策和行动能力，获得五角大楼的采购订单[9][10][11] - Kratos公司在2022年第四季度报告显示，营收同比增长10%，EBITDA也有所增长[12] 行业趋势 - 机器人将使人类从重复乏味的工作中解放出来，让他们更具创造力和创业精神，同时享受更多的休闲时间[2] - Intuitive Surgical公司在2023年第四季度报告显示，手术机器人需求快速增长，寻求FDA批准新产品[13][14][15]